We are live on ! Find out more
NTLA icon

Intellia Therapeutics
NTLA

165 hedge funds and large institutions have $1.12B invested in Intellia Therapeutics in 2020 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 69 increasing their positions, 33 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

109% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 33

101% more call options, than puts

Call options by funds: $3.84M | Put options by funds: $1.92M

1.32% more ownership

Funds ownership: 94.85% → 96.17% (+1.3%)

4% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 25

1% more funds holding

Funds holding: 164 → 165 (+1)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

1% less capital invested

Capital invested by funds: $1.13B → $1.12B (-$11.2M)

Holders
165
Holders Change
+1
Holders Change %
+0.61%
% of All Funds
3.33%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
26
Increased
69
Reduced
33
Closed
25
Calls
$3.84M
Puts
$1.92M
Net Calls
+$1.93M
Net Calls Change
-$1.26M

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$15.4M
2
BlackRock
BlackRock
New York
+$12.4M
3
Goldman Sachs
Goldman Sachs
New York
+$8.64M
4
Morgan Stanley
Morgan Stanley
New York
+$8.48M
5
Millennium Management
Millennium Management
New York
+$6.85M

Top Sellers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
-$8.79M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.79M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$4.54M
4
O
OrbiMed
New York
-$2.88M
5
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
-$2.77M
Name Holding Trade Value Shares
Change 		Change in
Stake
Principal Financial Group
176
Principal Financial Group
Iowa
– -$219K -10,437 Closed
MIC
177
Meridian Investment Counsel
California
– -$210K -10,000 Closed
SPM
178
Symmetry Peak Management
Pennsylvania
– -$200K -9,500 Closed
FC
179
FORA Capital
Florida
– -$185K -8,807 Closed
FMTCOCP
180
Farmers & Merchants Trust Co of Chambersburg PA
Pennsylvania
– -$35K -1,650 Closed
CWC
181
Carolinas Wealth Consulting
North Carolina
– -$21K -1,000 Closed
KPW
182
Kore Private Wealth
New York
– -$21K -1,000 Closed
APWM
183
Atlas Private Wealth Management
New York
– -$14K -676 Closed
PAG
184
Private Advisor Group
New Jersey
– -$11K -513 Closed
TI
185
tru Independence
Oregon
– -$4 -222 Closed
LC
186
Lindbrook Capital
California
– -$4K -187 Closed
TCM
187
Tradewinds Capital Management
Washington
– -$2K -100 Closed
TWA
188
TCI Wealth Advisors
Arizona
– -$209 -10 -33%
ASN
189
Advisory Services Network
Georgia
– +$167 +8 New
BWM
190
Baystate Wealth Management
Massachusetts
– +$417 +20 New
4 5 6 7
8

NTLA Hedge Fund Activity: Q3 2020 in Review

165 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Intellia Therapeutics (NTLA) for Q3 2020, worth a combined $1.12B — down 1% from $1.13B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new NTLA positions and 25 closed out — a net gain of 1 holder — while 69 added to existing stakes and 33 trimmed.

The largest buyer was State Street, adding an estimated $15.4M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $8.79M sold.

  • 165 institutional investors held Intellia Therapeutics (NTLA) as of Q3 2020, up from 164 in Q2 2020.
  • Funds reported $1.12B of Intellia Therapeutics stock for Q3 2020, down 1% quarter-over-quarter.
  • 26 funds opened new Intellia Therapeutics positions in Q3 2020 and 25 closed out, a net change of +1 holder.
  • The largest Intellia Therapeutics buyer in Q3 2020 was State Street, an estimated $15.4M added.
  • The largest Intellia Therapeutics seller in Q3 2020 was Avidity Partners Management, an estimated $8.79M sold.

Based on aggregated 13F filings for Q3 2020.